The efficacy of traditional lead-based systems is limited due to their size. Standard leads are too large traverse beyond epicardial vessels, particularly on the left side heart where endovascular placement less practical. Our lab has developed an in-situ curing, biostable, conductive hydrogel, or “liquid wire”, capable filling venous tributary branches and thus accessing mid-myocardial regions...